Category: Press Releases

Metalpha is focused on serving institutional investors and high-net-worth individuals, while also emphasizing its commitment to transparency and regulatory compliance

HONG KONG, Jan. 17, 2023 (GLOBE NEWSWIRE) — Dragon Victory International Limited (NASDAQ: LYL) announces it has officially changed its name to Metalpha Technology Holding Limited (NASDAQ: MATH) (the “Company”). The Company has also successfully completed restructuring with Antalpha Technologies Limited (“Antalpha”).

Upon completion of the reorganization, Metalpha Limited (“Metalpha”) will become a wholly-owned subsidiary of the Company. Established in 2021, Metalpha is a leading digital assets wealth management company headquartered in Hong Kong. The company works with clients to create tailor-made instruments that enable sophisticated investors to establish or liquidate investment positions or undertake hedging strategies.

This reorganization demonstrates a high level of confidence that the Company’s management team has in Metalpha’s ability to increase its presence and develop a competitive advantage under the current market conditions. The reorganization is intended to pave the way for new opportunities for Metalpha to become a global leader in digital asset wealth management. Metalpha employs finance talents with deep experience in derivatives and structured products, many of whom formerly worked at industry-leading banks such as Goldman Sachs, Morgan Stanley, and UBS.

“The crypto industry continues to have room for growth, despite its challenges this year. We are looking very closely at how to build a stronger and healthier global market for digital assets, which we are doing together with our partners, such as Antalpha, and many others,” said Founder and CEO Adrian Wang.

Metalpha aims to provide customers with high-quality product design and trading capabilities in the industry and is committed to delivering the best structured derivative products to cryptocurrency market participants. The company does not offer services to Mainland China and pursues the highest level of compliance standards in every jurisdiction it operates in.

Looking ahead, the Company will actively work with regulators on various compliance measures and plans to invest in supporting public education in blockchain technology and hiring more personnel at its headquarters in Hong Kong.

About Metalpha Limited

Established in 2021, Metalpha Limited is a global digital assets wealth management company headquartered in Hong Kong. The company hires top talents from Wall Street banks and provides crypto derivative products to institutions, which include exchanges, miners, funds, family offices, etc. Backed by both Metalpha Technology Holding Limited (NASDAQ: MATH) and Antalpha Technologies Limited, the company is one of the largest derivatives traders in Asia.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties, including the further spread of the COVID-19 virus or new variants thereof, or the occurrence of another wave of cases and the impact it may have on the Company’s operations and the demand for the Company’s services, and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to,” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and its other filings with the U.S. Securities and Exchange Commission.

Contact

Sissy Wang
info@metalpha.finance

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f833b6db-cfdf-45f7-8153-47657357042f

GlobeNewswire Distribution ID 8730701

BioMed X establishes its first US-based institute in New Haven with a new immunology research project in collaboration with AbbVie.

HEIDELBERG, Germany, Jan. 16, 2023 (GLOBE NEWSWIRE) — BioMed X, an independent German biomedical research institute, announced today the extension of its ongoing research collaboration with AbbVie. This marks the launch of the first BioMed X Institute in the US, to be located in New Haven, Connecticut. Following a first joint research project on Alzheimer’s disease at the BioMed X Institute in Heidelberg, Germany, the new US-based research collaboration will focus on immunology and tissue engineering.

“Extending our successful partnership with AbbVie to our new site in the US is a big milestone for our institute,” said Christian Tidona, Founder and Managing Director of BioMed X. “We are grateful to be able to bring our unique innovation model to New Haven and Yale University, one of the top places in the world for groundbreaking discoveries in biomedical research,” added Tidona.

The new BioMed X Institute will be managed by Mark Johnston, an experienced biotech entrepreneur and business leader who recently joined the BioMed X family. “My role is to synergize the BioMed X know-how with the invaluable local resources in New Haven to add a new dimension to the global BioMed X network,” explained Johnston. Neighboring the historic campus of Yale University, the US branch of BioMed X will be embedded in the New Haven life sciences hub. “Yale is devoted to academic leadership as well as global strategic partnerships to foster innovation and an entrepreneurial spirit. We welcome BioMed X to our biosciences community and appreciate the opportunities this alliance ushers in, including cooperation with international industry partners and networking with the European biotech ecosystem,” said Josh Geballe, Managing Director at Yale Ventures.

BioMed X was founded 10 years ago on the campus of one of Europe’s most renowned universities in the life sciences and medicine, the University of Heidelberg, operating at the interface between academia and industry. With its unique innovation model, BioMed X identifies the world’s best early career academic scientists and relocates them to a BioMed X institute to solve a major challenge in biomedical research in close collaboration with a global pharmaceutical company.

Our industry’s understanding of human disease biology is limited by the availability of relevant model systems that truly mirror the complexity of diseased human tissues, which hampers drug discovery and development. There are currently no good ex vivo models available involving human immune cells migrating through an organotypic human tissue microenvironment and recapitulating the molecular processes that typify human disease both spatially and temporally. Such models would allow for the generation of new insights into human disease biology, the identification and validation of new drug targets, and the development of new therapeutic concepts for the treatment of immune-mediated inflammatory conditions.

The current partnership with AbbVie is focused on the development of a new tissue engineering platform to produce complex human ex vivo models (disease-on-a-chip) from primary human cells and tissues to study human tissue inflammation. Interested candidates who would like to start or join a new fully funded research group at the BioMed X Institute in New Haven are invited to apply by submitting a project proposal via the BioMed X Career Space https://career.bio.mx/call/2023-NHV-C01 before March 12, 2023.

“AbbVie is encouraged by the potential of this collaboration with BioMed X to change the paradigm in drug discovery and expand the understanding of human disease biology,” said Timothy Radstake, Executive Director and Head of Early Immunology Discovery at AbbVie.

About BioMed X

BioMed X is an independent research institute located on the campus of the University of Heidelberg in Germany, with a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

Contact Information:
Flavia-Bianca Cristian
Recruiting & Communications Manager
fbc@bio.mx
+49 6221 426 11 706

Related Images

Image 1: BioMed X Logo

BioMed X Logo

Image 2: AbbVie Call Visual

This content was issued through the press release distribution service at Newswire.com.

Attachment

• BioMed X Logo

GlobeNewswire Distribution ID 8730017

MONACO, Jan. 16, 2023 (GLOBE NEWSWIRE) — At 4:10pm precisely on Sunday 15th January the gun fired for the start of The Ocean Race from Alicante, Spain, for the 5 IMOCA boats and 6 Volvo 65s including the 5 team members sailing on Malizia-Seaexplorer helmed by Boris Herrmann from Yacht Club de Monaco. The former Whitbread Round The World Race continues to thrill 50 years after it first launched. For the second time in its history, YCM is on the start of this crewed round the world in stages offshore race after Grant Dalton’s 2nd place in 1997-1998 on WOR 60 Merit Cup (MON 700).

For YCM’s Boris Herrmann it’s his first crack at this iconic race in his career. Aboard Malizia-Seaexplorer it will be a unique experience for the sailor and his crew comprising Will Harris(co-skipper), Rosalin Kuiper, Nicolas Lunven, Yann Eliès, Axelle Pillain and Antoine Auriol (on board reporter). Having left the yard last July, the brand new 60-footer already has a taste for offshore having competed in the Route du Rhum. “The sensations on this boat are completely different. It’s slightly heavier with a slight banana-shape to the hull that entails a different approach to navigation. It’s also higher which means more space inside and that improves quality of life for all on board,” says Pierre Casiraghi, YCM Vice-President and founder of Team Malizia. “The boat’s designed for the Vendée Globe, so solo sailing, but also with crew for The Ocean Race. It also has many more sensors and electronics. I think Boris and Team Malizia will do very well in this race. He has a lot of experience sailing all over the world with many different teams and boats, whether as crew on Maserati (MOD70) or racing with Francis Joyon on Idec (Ultime) among others.” After damage incurred during the recent Route du Rhum, the 60-footer was in the yard to have foils replaced: “We’re trying to work out exactly what happened but it’s not that unusual with such recent foils,” explains Boris Herrmann, “The team did an incredible job and turned the situation round in record time.” The crew on Malizia-Seaexplorer then return to Monaco in time for the 10th Monaco Energy Boat Challenge.

The technical set-back failed to put the brakes on the team’s ambitions as Malizia-Seaexplorer got off to a cracking start, winning the first In-Port race (Alicante) on 8th January a week before the start.

Launched 1973 and held every three years since 1988, it is the first time the high tech, foiling, nearly flying IMOCA boats will be competing. Nine stage cities are on the programme for the next six months. The first stage is a 1,900 nautical mile sprint to Cape Verde, a first stop that will allow competitors to focus on sustainability issues at the famous Ocean Week, a cause dear to the hearts of the crew on Malizia-Seaexplorer and the Yacht Club de Monaco.

Starting 25th January, Leg 2 sees the fleet head to Cape Town, South Africa, before setting sail again for a recordbreaking distance to Itajaí in Brazil. At 12,750 nautical miles, it’s the longest leg in the event’s history and takes the IMOCAs and VO65s into the Roaring Forties and Furious Fifties of the Southern Ocean. With the Antarctic to starboard, the fleet need to pass all three of the great southern capes – Cape of Good Hope, Cape Leeuwin and Cape Horn – to port and without stopping. From there they head north, through the doldrums again to Newport, Rhode Island, on the east coast of the United States, before returning to Europe with a transatlantic leg to Aarhus, Denmark, followed by a fly-by of Kiel, Germany, before a stop in The Hague in The Netherlands. Then it’s the Grand Finale leg to Genova, Italy, with first arrivals expected 1st July 2023.

For more information:

LaPresse SpA Communication and Press Office Director
Barbara Sanicola – barbara.sanicola@lapresse.it

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/597c8b73-9734-4474-b4e0-bbca87740aba

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

GlobeNewswire Distribution ID 8730162

• CognivAiD provides a long-awaited option to fulfil the unmet needs of patients with vascular dementia.
• CognivAiD demonstrated significant and clinically meaningful disease-modifying benefits in clinical trials based on VaDAS-Cog and ADCS-CGIC scales, with a favourable safety profile.
• CognivAiD has a unique ‘multimodal mechanism of action’, reinforcing Moleac’s dedication to developing scientifically proven innovative formulations for patients with neurological conditions.

SINGAPORE, Jan. 16, 2023 (GLOBE NEWSWIRE) — Moleac announced on 29^th October 2022 the launch of CognivAiD, the first-in-market specific product for Vascular Dementia (VaD). An optimized formulation of active extracts from Gingko, Ginseng and Saffron, CognivAiD shows significant and clinically meaningful disease-modifying benefits in patients with VaD, a condition with no targeted treatment at present.

David Picard, CEO of Moleac, commented on the launch: “Moleac focuses on neurology to help patients reconnect with their lives. Over the past 20 years, we have built a unique platform to develop and bring to patients innovative medicines meeting their needs in neurology. This was done with our flagship product NeuroAiDII, which currently benefits patients from over 35 countries. Our strategy now is to leverage our expertise, infrastructure and partners to bring more therapies to those suffering from a loss of brain functions. We are very proud to launch CognivAiD which fills a big gap in the treatment of vascular dementia and the cognitive disorders it causes.”

More than 55 million people currently live with dementia globally, with an incidence of over 10 million cases every year. This presents a huge financial and economic burden, amounting to an annual global cost of US$1.3 trillion that is expected to rise to US$2.8 trillion by 2030¹. Vascular dementia, the second most common subtype of dementia after Alzheimer’s disease, accounts for 15-30% of all dementia cases².

The current treatment options for VaD include acetylcholinesterase inhibitors (AChE inhibitors) such as donepezil, and NMDA antagonists such as memantine. However, these options do not specifically target the key mechanisms of VaD.

“There are currently very few therapeutic options available for patients with VaD. The existing options are non-specific with modest documented benefits, and they may have undesirable side effects in this frail population. Thanks to years of research in the lab and in clinical trials, CognivAiD is now available as a new therapeutic option, slowing down the cognitive decline of VaD patients and helping them to maintain their daily living activities. It targets the complex disease pathways of VaD via its properties of vascular protection, vasoregulation, and modulation of neuroinflammation. Its efficacy and safety are well-established in rigorous clinical trials published in peer-reviewed journals. We are proud at Moleac to provide access to CognivAiD, a new safe and effective treatment that will benefit VaD patients and their caregivers,” said Dr. Sylvain Durrleman, Head of Medical Affairs at Moleac.

For more information, visit www.cognivaid.com.

About CognivAiD

CognivAiD is an evidence-based formulation comprising active extracts from Croci Stigma, Ginkgo Folium and Ginseng Radix et Rhizoma which has been shown to be safe and effective for the treatment of vascular dementia.

About Moleac

Moleac is a biopharmaceutical company committed to helping patients and families reconnect with their lives. Headquartered in Singapore, we are dedicated to developing scientifically proven innovative formulations that bridge therapeutic gaps and address unmet needs of patients with neurological conditions such as stroke, traumatic brain injuries and dementia.

Moleac’s flagship product NeuroAiDII reaches more than 30,000 patients in over 35 countries every year. CognivAiD, the company’s new product for vascular dementia, was launched in October 2022.

For more information, visit www.moleac.com.

Name of Press Contact: Clement Dif

Phone: +65 6211 3710

Email: communication@moleac.com

GlobeNewswire Distribution ID 8730125

---

• Call comes ahead of World Economic Forum annual meeting
• Schneider-commissioned research finds most companies planning to spend under 2% of revenues on sustainability and decarbonization initiatives
• On the demand side of the energy transition, only 31% of organizations currently push electrification as a way to decarbonize

Rueil-Malmaison (France), January 16, 2023 – Schneider Electric, the leader in the digital transformation of energy management and automation, today issued an urgent call for governments and companies around the world to accelerate their sustainability action and step up investments into technologies that will help them reduce their carbon emissions and bolster their energy security.

The call comes amid spiking energy prices, an energy supply crisis and fast accelerating climate change, which together pose major challenges for companies, economies and societies around the globe. These challenges form the backdrop for the World Economic Forum’s annual meeting in Davos, Switzerland, from 16-20 January, which senior Schneider Electric executives will attend.

“Today’s climate and energy crises are an economic reality for ever-increasing numbers of people. As business leaders and policymakers come together at Davos, we must act in our own best long-term, not short-term, interests,” said Jean-Pascal Tricoire, Schneider Electric’s Chairman and CEO.  “We must not avoid the tough decisions. There can be no long-term prosperity without a complete energy transition. At Schneider, our approach is to ‘Digitize Strategize, Decarbonize’ – businesses, governments and societies must do this now, to make good on the commitments they have made.“

With 38% of global CO₂ emissions coming from the built environment, and a further 32% from industry¹, Schneider Electric’s products, software and services in the areas of industrial automation and energy management help companies, industries, building managers and households to decarbonize and digitize their energy usage. Schneider Electric also offers deep insights into decarbonization trends and solutions, through surveys, research and in-depth reports compiled by the Schneider Electric Sustainability Research Institute.

An independent survey of more than 500 C-suite executives commissioned by Schneider last year  found that corporate sustainability commitments and investments are often hampered by the complexity of decarbonization. On average, the financial commitment to sustainability and decarbonization initiatives across the companies surveyed was less than 2% of projected revenue over the next three years – despite the fact such investments are often efficient and cost-effective, with return on investment often under one to three years.
Respondents highlighted stakeholder alignment, budget, technology, skills and regulation as challenges to sustainability implementation. However, a majority noted that enhanced industrial automation and the upgrading of electrical infrastructure will form a key part of their sustainability plan for the next three years.

Renewable energy procurement is among the top initiatives pursued on the supply side, while electrification – a key demand-side measure – scores low among organizations’ sustainability priorities. Alongside electrification, delivering increased efficiency across existing infrastructure through digitization and automation will be among the most important levers in the next decade, being the fastest and most capital-efficient means for many organizations to reduce emissions.

Embracing sustainability as a business imperative, with digital solutions key to navigating the global energy crisis

A further recent Schneider Electric report on the EU’s electrification potential found that focusing on sectors in which electrification is both feasible and attractive could raise electricity’s share of the energy mix from around 20% to 50%. In turn, the share of natural gas and oil would drop by around 50%, contributing significantly to improved energy security. Schneider Electric offers specific, practical solutions to help companies navigate this transition more quickly and efficiently.

Schneider Electric points out that today’s European energy crisis follows decades of secure, reliably available energy and relatively stable pricing. Many are experiencing for the first time unpredictable energy supplies and unaffordable prices, demonstrating a failure both of long-term energy security preparedness, and of the implementation of decarbonization plans. This in turn underscores the importance of reevaluating the entire energy equation, from the supply side (energy transition) to the demand side (energy efficiency).

“Purpose and profits must align to become powerful forces in the fight against climate change,” said Mr. Tricoire. “We already have the technology to avert the energy and climate crises, and to deliver safe, reliable, and sustainable energy distribution and energy use. Our data-driven approach, spanning industrial automation, digitization and the digital twin technology of the enterprise metaverse, combines to unlock a brighter, more sustainable and more prosperous future. The urgency for action has never been greater than it is now.”

About Schneider Electric

Schneider’s purpose is to empower all to make the most of our energy and resources, bridging progress and sustainability for all. We call this Life Is On.

Our mission is to be your digital partner for Sustainability and Efficiency.

We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure and industries.

We are the most local of global companies. We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive and Empowered values.

¹ IEA Global Energy Review: CO2 Emissions, 2021

GlobeNewswire Distribution ID 1000777376